Back
Phathom Pharmaceuticals, Inc. Vs. AXT, Inc. Industry Stock Comparison
Buy
54
PHAT
Phathom Pharmaceuticals, Inc.
Last Price:
$11.34
Seasonality Move:
28.51%
Sell
42
AXTI
AXT, Inc.
Last Price:
$52.95
Seasonality Move:
9.66%
Buy
54
Phathom Pharmaceuticals, Inc. (PHAT)
is a Buy
Is Phathom Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Phathom Pharmaceuticals, Inc. [PHAT] share price is $11.34. The Score for PHAT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
PHAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
AXT, Inc. (AXTI)
is a Sell
Is AXT, Inc. a Buy, Sell or Hold?
-
AXTI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals, Inc.'s stock price today?
-
The Phathom Pharmaceuticals, Inc. share price today is $11.34The current trend is relatively stagnant and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
AXTI Stock Price Chart
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 51.78 | Buy |
| Chaikin Money Flow: | 703575 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.42 - 11.4) | Buy |
| Bollinger Bands (100): | (11.51 - 15.67) | Sell |
AXTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.28 | Buy |
| Relative Strength Index (14 RSI): | 53.39 | Buy |
| Chaikin Money Flow: | 15364772 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.44 - 59.16) | Buy |
| Bollinger Bands (100): | (10.03 - 41.59) | Buy |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.75 | Buy |
| 20-day SMA: | 10.79 | Buy |
| 50-day SMA: | 11.89 | Sell |
| 200-day SMA: | 12.28 | Sell |
| 8-day EMA: | 10.94 | Buy |
| 20-day EMA: | 11.01 | Buy |
| 50-day EMA: | 11.85 | Sell |
| 200-day EMA: | 11.95 | Sell |
AXTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.08 | Sell |
| 20-day SMA: | 52.05 | Buy |
| 50-day SMA: | 36.82 | Buy |
| 200-day SMA: | 14.71 | Buy |
| 8-day EMA: | 54.71 | Sell |
| 20-day EMA: | 51.49 | Buy |
| 50-day EMA: | 40.68 | Buy |
| 200-day EMA: | 20.19 | Buy |
Phathom Pharmaceuticals, Inc. Earnings Growth & PHAT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.07 per share, an increase this year of $2.34 per share, and an increase next year of $1.53 per share.
AXT, Inc. Earnings Growth & AXTI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.05 per share, an increase this year of $0.42 per share, and an increase next year of $0.46 per share.
Phathom Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AXT, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||